11q deletion in neuroblastoma: a review of biological and clinical implications
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
11q deletion in neuroblastoma: a review of biological and clinical implications
Authors
Keywords
Neuroblastoma, 11q deletion, MYCN amplification, Cancer, Development, Metastasis, Review
Journal
Molecular Cancer
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-06-29
DOI
10.1186/s12943-017-0686-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma
- (2016) Lori S. Hart et al. CLINICAL CANCER RESEARCH
- Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
- (2016) Andrew C. Wood et al. CLINICAL CANCER RESEARCH
- Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait
- (2016) Anneleen Decock et al. Epigenetics
- The genetic tumor background is an important determinant for heterogeneousMYCN-amplified neuroblastoma
- (2016) Dominik Bogen et al. INTERNATIONAL JOURNAL OF CANCER
- Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma
- (2016) John T. Powers et al. NATURE
- Neuroblastoma
- (2016) Katherine K. Matthay et al. Nature Reviews Disease Primers
- Coexistence of neuroblastoma and ganglioneuroma in a girl with a hemizygous deletion of chromosome 11q14.1-23.3
- (2015) Tadashi Shiohama et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- MicroRNA-708 is downregulated in hepatocellular carcinoma and suppresses tumor invasion and migration
- (2015) Guangjun Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations
- (2015) Kristopher R. Bosse et al. CANCER
- A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis
- (2015) Robert W. Schnepp et al. CANCER CELL
- The role of miR-100-mediated Notch pathway in apoptosis of gastric tumor cells
- (2015) Geng Yang et al. CELLULAR SIGNALLING
- Let-7 and miR-125 cooperate to prime progenitors for astrogliogenesis
- (2015) A. Shenoy et al. EMBO JOURNAL
- Lin28B and Let-7 in the Control of Sympathetic Neurogenesis and Neuroblastoma Development
- (2015) M. Hennchen et al. JOURNAL OF NEUROSCIENCE
- Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
- (2015) Thomas F Eleveld et al. NATURE GENETICS
- Mutational dynamics between primary and relapse neuroblastomas
- (2015) Alexander Schramm et al. NATURE GENETICS
- Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors
- (2015) A P Berbegall et al. ONCOGENE
- Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma Group
- (2015) Katia Mazzocco et al. PEDIATRIC BLOOD & CANCER
- Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B
- (2015) Kai-Ti Lin et al. Nature Communications
- Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism
- (2015) Stefano J. Mandriota et al. Oncotarget
- The role of miR-100 in regulating apoptosis of breast cancer cells
- (2015) Yi Gong et al. Scientific Reports
- Downregulation of microRNA-100 enhances the ICMT-Rac1 signaling and promotes metastasis of hepatocellular carcinoma cells
- (2015) Hui-Chao Zhou et al. Oncotarget
- Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification
- (2014) R Defferrari et al. BRITISH JOURNAL OF CANCER
- microRNA-125 distinguishes developmentally generated and adult-born olfactory bulb interneurons
- (2014) M. Akerblom et al. DEVELOPMENT
- Recent insights into the biology of neuroblastoma
- (2014) Gudrun Schleiermacher et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic value of microRNA-100 in esophageal squamous cell carcinoma
- (2014) Shu Zhou et al. JOURNAL OF SURGICAL RESEARCH
- Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer
- (2014) Peng Chen et al. MEDICAL ONCOLOGY
- The neuroblastoma and ganglion components of nodular ganglioneuroblastoma are genetically similar: evidence against separate clonal origins
- (2014) Paola Angelini et al. MODERN PATHOLOGY
- Significance of clinical and biologic features in Stage 3 neuroblastoma: A report from the International Neuroblastoma Risk Group project
- (2014) Holly J. Meany et al. PEDIATRIC BLOOD & CANCER
- Low expression of let-7 predicts poor prognosis in patients with multiple cancers: a meta-analysis
- (2014) Yang Xia et al. TUMOR BIOLOGY
- DNA replication stress in CHK1-depleted tumour cells triggers premature (S-phase) mitosis through inappropriate activation of Aurora kinase B
- (2014) P Zuazua-Villar et al. Cell Death & Disease
- Association between miR34b/c Polymorphism rs4938723 and Cancer Risk: A Meta-Analysis of 11 Studies including 6169 Cases and 6337 Controls
- (2014) Baiyong Shen MEDICAL SCIENCE MONITOR
- Let-7 microRNA-binding-site polymorphism in the 3′UTR ofKRASand colorectal cancer outcome: a systematic review and meta-analysis
- (2014) Scott M. Langevin et al. Cancer Medicine
- Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation
- (2013) Cihan Cetinkaya et al. BMC CANCER
- LIN28 Expression in Malignant Germ Cell Tumors Downregulates let-7 and Increases Oncogene Levels
- (2013) M. J. Murray et al. CANCER RESEARCH
- Chk1 Targeting Reactivates PP2A Tumor Suppressor Activity in Cancer Cells
- (2013) A. Khanna et al. CANCER RESEARCH
- Constitutional 11q14-q22 chromosome deletion syndrome in a child with neuroblastoma MYCN single copy
- (2013) Annalisa Passariello et al. European Journal of Medical Genetics
- Overexpression of microRNA-100 predicts an unfavorable prognosis in renal cell carcinoma
- (2013) Guihua Wang et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- miR-708 promotes the development of bladder carcinoma via direct repression of Caspase-2
- (2013) Tao Song et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The genetic landscape of high-risk neuroblastoma
- (2013) Trevor J Pugh et al. NATURE GENETICS
- Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program
- (2013) Andrew C. Wood et al. PEDIATRIC BLOOD & CANCER
- Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion
- (2013) Eva Villamón et al. PLoS One
- Pharmacological Inhibition of polysialyltransferase ST8SiaII Modulates Tumour Cell Migration
- (2013) Yousef M. J. Al-Saraireh et al. PLoS One
- Combination Therapy Targeting the Chk1 and Wee1 Kinases Shows Therapeutic Efficacy in Neuroblastoma
- (2012) M. R. Russell et al. CANCER RESEARCH
- Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers
- (2012) J. S. Jang et al. CLINICAL CANCER RESEARCH
- CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs
- (2012) M. I. Walton et al. CLINICAL CANCER RESEARCH
- Small temporal RNAs in animal development
- (2012) Nicholas S Sokol CURRENT OPINION IN GENETICS & DEVELOPMENT
- Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer
- (2012) Sheng Wang et al. Diagnostic Pathology
- Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma
- (2012) Simona Coco et al. INTERNATIONAL JOURNAL OF CANCER
- Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
- (2012) Nai-Kong V. Cheung JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
- (2012) Jan J. Molenaar et al. NATURE
- Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
- (2012) Sharon J Diskin et al. NATURE GENETICS
- LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
- (2012) Jan J Molenaar et al. NATURE GENETICS
- Epigenetic inactivation of the MIR34B/C in multiple myeloma
- (2011) K. Y. Wong et al. BLOOD
- Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma
- (2011) J Buechner et al. BRITISH JOURNAL OF CANCER
- LIN28B Promotes Colon Cancer Progression and Metastasis
- (2011) C. E. King et al. CANCER RESEARCH
- MicroRNA-708 Induces Apoptosis and Suppresses Tumorigenicity in Renal Cancer Cells
- (2011) S. Saini et al. CANCER RESEARCH
- Unleashing Chk1 in cancer therapy
- (2011) Laura Carrassa et al. CELL CYCLE
- Copy number defects of G1-Cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosis
- (2011) Jan J. Molenaar et al. GENES CHROMOSOMES & CANCER
- GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma
- (2011) Fabienne Gumy-Pause et al. GENES CHROMOSOMES & CANCER
- HepaCAM induces G1 phase arrest and promotes c-Myc degradation in human renal cell carcinoma
- (2011) Qiao-Lin Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma
- (2011) E E Santo et al. ONCOGENE
- Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers
- (2011) Åslaug Helland et al. PLoS One
- RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma
- (2011) K. A. Cole et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuroblastoma in adolescents: genetic and clinical characterisation
- (2010) Victoria Castel et al. Clinical & Translational Oncology
- Chromosomal and MicroRNA Expression Patterns Reveal Biologically Distinct Subgroups of 11q- Neuroblastoma
- (2010) P. G. Buckley et al. CLINICAL CANCER RESEARCH
- Ongoing roles of Phox2 homeodomain transcription factors during neuronal differentiation
- (2010) E. Coppola et al. DEVELOPMENT
- Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J
- (2010) Wooi Loon Ng et al. DNA REPAIR
- Accumulation of Segmental Alterations Determines Progression in Neuroblastoma
- (2010) Gudrun Schleiermacher et al. JOURNAL OF CLINICAL ONCOLOGY
- High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
- (2010) H. Caren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Absence of polysialylated NCAM is an unfavorable prognostic phenotype for advanced stage neuroblastoma
- (2009) Miikka Korja et al. BMC CANCER
- Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
- (2009) Isabelle Janoueix-Lerosey et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA-125b Promotes Neuronal Differentiation in Human Cells by Repressing Multiple Targets
- (2009) M. T. N. Le et al. MOLECULAR AND CELLULAR BIOLOGY
- Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q
- (2009) M Fischer et al. ONCOGENE
- CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23
- (2008) Evi Michels et al. BMC CANCER
- Nutlin-3a Activates p53 to Both Down-regulate Inhibitor of Growth 2 and Up-regulate mir-34a, mir-34b, and mir-34c Expression, and Induce Senescence
- (2008) K. Kumamoto et al. CANCER RESEARCH
- Cyclin D1 and CDK4 Activity Contribute to the Undifferentiated Phenotype in Neuroblastoma
- (2008) J. J. Molenaar et al. CANCER RESEARCH
- Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells
- (2008) M. C. Moh et al. CARCINOGENESIS
- Expression ofTSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation
- (2008) Kiyohiro Ando et al. INTERNATIONAL JOURNAL OF CANCER
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- Early origins and evolution of microRNAs and Piwi-interacting RNAs in animals
- (2008) Andrew Grimson et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started